Business Description
DermTech Inc
NAICS : 621512
SIC : 8099
ISIN : VGG2379F1080
Description
DermTech Inc is an emerging growth molecular diagnostic company. The company is engaged in marketing and developing novel non-invasive genomic tests to aid in the diagnosis of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. While the company generates revenue through laboratory services.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.03 | |||||
| Equity-to-Asset | 0.47 | |||||
| Debt-to-Equity | 0.95 | |||||
| Debt-to-EBITDA | -0.56 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -6.8 | |||||
| Beneish M-Score | -2.91 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.6 | |||||
| 3-Year EBITDA Growth Rate | -13.5 | |||||
| 3-Year EPS without NRI Growth Rate | -14.1 | |||||
| 3-Year FCF Growth Rate | -9.9 | |||||
| 3-Year Book Growth Rate | -17.8 | |||||
| Future 3-5Y Total Revenue Growth Rate | 18.42 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 35.3 | |||||
| 9-Day RSI | 36.98 | |||||
| 14-Day RSI | 36.14 | |||||
| 6-1 Month Momentum % | -45.9 | |||||
| 12-1 Month Momentum % | -81.97 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.59 | |||||
| Quick Ratio | 4.52 | |||||
| Cash Ratio | 4.15 | |||||
| Days Inventory | 33.45 | |||||
| Days Sales Outstanding | 85.5 | |||||
| Days Payable | 46.71 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -18.5 | |||||
| Shareholder Yield % | -134.38 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 1.8 | |||||
| Operating Margin % | -678.21 | |||||
| Net Margin % | -659.57 | |||||
| FCF Margin % | -509.16 | |||||
| ROE % | -110.16 | |||||
| ROA % | -63.36 | |||||
| ROIC % | -143.18 | |||||
| ROC (Joel Greenblatt) % | -173.76 | |||||
| ROCE % | -71.82 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.31 | |||||
| PB Ratio | 0.35 | |||||
| Price-to-Tangible-Book | 0.35 | |||||
| EV-to-EBIT | -0.19 | |||||
| EV-to-EBITDA | -0.2 | |||||
| EV-to-Revenue | 1.29 | |||||
| EV-to-Forward-Revenue | 0.14 | |||||
| EV-to-FCF | -0.25 | |||||
| Earnings Yield (Greenblatt) % | -526.32 | |||||
| FCF Yield % | -384.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:DMTK
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
DermTech Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 15.296 | ||
| EPS (TTM) ($) | -3.14 | ||
| Beta | 3.48 | ||
| Volatility % | 81.03 | ||
| 14-Day RSI | 36.14 | ||
| 14-Day ATR ($) | 0.054227 | ||
| 20-Day SMA ($) | 0.636945 | ||
| 12-1 Month Momentum % | -81.97 | ||
| 52-Week Range ($) | 0.58 - 3.8984 | ||
| Shares Outstanding (Mil) | 34.62 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
DermTech Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
DermTech Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
DermTech Inc Frequently Asked Questions
What is DermTech Inc(DMTK)'s stock price today?
The current price of DMTK is $0.59. The 52 week high of DMTK is $3.90 and 52 week low is $0.58.
When is next earnings date of DermTech Inc(DMTK)?
The next earnings date of DermTech Inc(DMTK) is 2024-05-03 Est..
Does DermTech Inc(DMTK) pay dividends? If so, how much?
DermTech Inc(DMTK) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers